These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22446981)

  • 21. Population pharmacokinetics of cyclosporine A in Chinese patients with nephrotic syndrome in individualized drug administration
.
    Liu YO; Jia B; Chen CY; Zhou Y; Cui YM; Zhou FD
    Int J Clin Pharmacol Ther; 2020 Jan; 58(1):1-9. PubMed ID: 31319907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
    Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
    Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
    Yang X; Yang S; Sun A; Qiu H; Tang X; Han Y; Wu D
    Clin Transplant; 2018 Apr; 32(4):e13220. PubMed ID: 29493007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
    Xue L; Rui JZ; Zhang Y; Miao LY
    Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.
    Rosenbaum SE; Baheti G; Trull AK; Akhlaghi F
    Ther Drug Monit; 2005 Apr; 27(2):116-22. PubMed ID: 15795639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NONMEM population pharmacokinetic modeling of orally administered cyclosporine from routine drug monitoring data after heart transplantation.
    Parke J; Charles BG
    Ther Drug Monit; 1998 Jun; 20(3):284-93. PubMed ID: 9631925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patients.
    Song L; Huang CR; Pan SZ; Zhu JG; Cheng ZQ; Yu X; Xue L; Xia F; Zhang JY; Wu DP; Miao LY
    Expert Rev Clin Pharmacol; 2023 Jan; 16(1):83-91. PubMed ID: 36373407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a Bayesian Individualization of Cyclosporine Dosage Regimen for Children Undergoing Allogeneic Hematopoietic Cell Transplantation: A Cost-Effectiveness Analysis.
    Beyron C; Ceraulo A; Bertrand Y; Bleyzac N; Philippe M
    Ther Drug Monit; 2021 Aug; 43(4):481-489. PubMed ID: 33814541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Int J Hematol; 2009 Jul; 90(1):103-107. PubMed ID: 19472033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Bianchi M; Heim D; Lengerke C; Halter J; Gerull S; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Ann Hematol; 2019 Apr; 98(4):971-977. PubMed ID: 30542943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting oral cyclosporin disposition after heart transplantation: bootstrap validation of a population pharmacokinetic model.
    Parke J; Charles BG
    Eur J Clin Pharmacol; 2000 Sep; 56(6-7):481-7. PubMed ID: 11049011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
    Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
    Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring Data.
    Albitar O; Ballouze R; Harun SN; Mohamed Noor DA; Sheikh Ghadzi SM
    J Clin Pharmacol; 2020 Nov; 60(11):1474-1482. PubMed ID: 32557653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
    Nara M; Takahashi N; Miura M; Niioka T; Kagaya H; Fujishima N; Saitoh H; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1321-9. PubMed ID: 23354810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients.
    Lukas JC; Suárez AM; Valverde MP; Calvo MV; Lanao JM; Calvo R; Suarez E; Gil AD
    J Clin Pharm Ther; 2005 Dec; 30(6):549-57. PubMed ID: 16336287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.
    Wu X; Xie H; Lin W; Yang T; Li N; Lin S; Yuan X; Ren J; Li X; Huang X
    Clin Exp Pharmacol Physiol; 2017 May; 44(5):529-538. PubMed ID: 28135768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.